Matthew Hammill

Title: Innovations of Matthew Hammill in Gene Silencing

Introduction

Matthew Hammill is an accomplished inventor based in Cobourg, Canada. He has made significant contributions to the field of gene silencing through his innovative research and development. His work focuses on creating advanced systems that can be utilized in both therapeutic and research applications.

Latest Patents

Matthew Hammill holds a patent for a "System and method for reversible photo-controlled gene silencing." This invention involves a chemically-modified siRNA that allows for reversible control of gene silencing through light exposure. The siRNA is designed with nucleotides in the sense strand replaced by a spacer that includes an azobenzene or its derivatives. This azobenzene undergoes isomerization between trans and cis configurations when exposed to light, enhancing RNA silencing activity in the trans configuration. This innovative approach has potential applications in therapeutics and research tools.

Career Highlights

Matthew Hammill is affiliated with the University of Ontario Institute of Technology, where he continues to advance his research in gene silencing technologies. His work has garnered attention for its potential to revolutionize the way gene expression is controlled in various biological contexts.

Collaborations

Matthew collaborates with Jean-Paul Desaulniers, contributing to the advancement of their shared research interests. Their partnership exemplifies the collaborative spirit of innovation in the scientific community.

Conclusion

Matthew Hammill's contributions to gene silencing through his patented innovations highlight the importance of research in biotechnology. His work not only enhances our understanding of gene regulation but also opens new avenues for therapeutic applications.